CTLA4 and breast carcinoma: There is a significant body of evidence documenting the important contribution by circulating and tumour-infiltrating T effector (CD4+ and CD8+) and regulatory (FOXP3+ and CTLA-4+) cells and NK cells in immune-mediated breast cancer cell death in women with LLABCs undergoing NAC.